Which rate is typically used to evaluate a healthcare capital project, and what might modify it?

• A. Internal rate of return (IRR) for the project.
• B. Weighted Average Cost of Capital (WACC) or a modified rate reflecting project risk and the cost of funds.
• C. The cost of the most expensive capital project planned.
• D. The risk-free rate plus a fixed risk premium.

Answer: (B)

The rate used to evaluate a healthcare capital project should reflect the opportunity cost of the funds and the risk of the project. The standard choice is the weighted average cost of capital (WACC), which blends the costs of debt and equity in the firm’s capital structure (after taxes) according to how the project is financed. Analysts may adjust this rate for project-specific risk, adding a risk premium or otherwise tailoring the discount rate to reflect regulatory, reimbursement, demand, or technology uncertainties that are particular to the project. This approach ensures the hurdle rate aligns with what investors require given the firm’s overall risk and financing mix.

Using the project’s own internal rate of return would describe the return the project generates, not the required rate used to discount its cash flows. The cost of the most expensive capital project planned is not a standard metric for evaluating a new project and would misrepresent the true opportunity cost of funds. A simple risk-free rate plus a fixed risk premium is overly simplistic and ignores the actual mix of debt and equity, tax effects, and how different risks are financed, making WACC (with possible adjustments) the more robust framework.